Production of high-affinity human monoclonal antibody fab fragments to the 19-kilodalton C-terminal merozoite surface protein 1 of Plasmodium falciparum

Infection and Immunity

Volumn 75, Issue 7, 2007, Pages 3614-3620

  Cheng, Xun Jia ^a,b   Hayasaka, Hitoshi ^a   Watanabe, Katsuomi ^a   Tao, Yan Lin ^b   Liu, Jin Ye ^b   Tsukamoto, Hideo ^a   Horii, Toshihiro ^c   Tanabe, Kazuyuki ^c   Tachibana, Hiroshi ^a  

^a TOKAI UNIVERSITY   (Japan)

^b FUDAN UNIVERSITY   (China)

^c OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; IMMUNOGLOBULIN F(AB) FRAGMENT; IMMUNOGLOBULIN HEAVY CHAIN; MEROZOITE SURFACE PROTEIN 1; RECOMBINANT PROTEIN;

ANIMAL CELL; ANTIBODY SPECIFICITY; ARTICLE; BACTERIAL GENE; BINDING AFFINITY; CARBOXY TERMINAL SEQUENCE; CELL INVASION; COMBINATORIAL LIBRARY; CONTROLLED STUDY; DISSOCIATION CONSTANT; ERYTHROCYTE; GENE EXPRESSION; GENETIC CONSERVATION; GENETIC RECOMBINATION; GERM LINE; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOGLOBULIN GENE; MALARIA; MEROZOITE; NONHUMAN; NUCLEOTIDE SEQUENCE; PERIPHERAL LYMPHOCYTE; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; SCHIZONT; SCREENING; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; TROPHOZOITE;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, MONOCLONAL; COMBINATORIAL CHEMISTRY TECHNIQUES; ERYTHROCYTES; GENE LIBRARY; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOGLOBULIN LIGHT CHAINS; IMMUNOGLOBULIN VARIABLE REGION; MALARIA, FALCIPARUM; MEROZOITE SURFACE PROTEIN 1; MEROZOITES; MOLECULAR SEQUENCE DATA; PLASMODIUM FALCIPARUM; RECOMBINANT PROTEINS; SEQUENCE ANALYSIS, DNA;

EID: 34447287394     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.00062-07     Document Type: Article

References (49)

1. Barbas, C. F., III, E. Bjorling, F. Chiodi, N. Dunlop, D. Cababa, T. M. Jones, S. L. Zebedee, M. A. Persson, P. L. Nara, E. Norrby, et al. 1992. Recombinant human Fab fragments neutralize human type 1 immunodeficiency virus in vitro. Proc. Natl. Acad. Sci. USA 89:9339-9343.
2. Bird, R. E., K. D. Hardman, J. W. Jacobson, S. Johnson, B. M. Kaufman, S. M. Lee, T. Lee, S. H. Pope, G. S. Riordan, and M. Whitlow. 1988. Single-chain antigen-binding proteins. Science 242:423-426.
3. Blackman, M. J., H. G. Heidrich, S. Donachie, J. S. McBride, and A. A. Holder. 1990. A single fragment of a malaria merozoite surface protein remains on the parasite during red cell invasion and is the target of invasion-inhibiting antibodies. J. Exp. Med. 172:379-382.
4. Blackman, M. J., T. J. Scott-Finnigan, S. Shai, and A. A. Holder. 1994. Antibodies inhibit the protease-mediated processing of a malaria merozoite surface protein. J. Exp. Med. 180:389-393.
5. Chappel, J. A., and A. A. Holder. 1993. Monoclonal antibodies that inhibit Plasmodium falciparum invasion in vitro recognise the first growth factor-like domain of merozoite surface protein-1. Mol. Biochem. Parasitol. 60:303-311.
6. Cheng, X. J., S. Ihara, M. Takekoshi, and H. Tachibana. 2000. Entamoeba histolytica: bacterial expression of a human monoclonal antibody which inhibits in vitro adherence of trophozoites. Exp. Parasitol. 96:52-56.
7. Daly, T. M., and C. A. Long. 1995. Humoral response to a carboxyl-terminal region of the merozoite surface protein-1 plays a predominant role in controlling blood-stage infection in rodent malaria. J. Immunol. 155:236-243.
8. Egan, A. F., P. Burghaus, P. Druilhe, A. A. Holder, and E. M. Riley. 1999. Human antibodies to the 19 kDa C-terminal fragment of Plasmodium falciparum merozoite surface protein 1 inhibit parasite growth in vitro. Parasite Immunol. 21:133-139.
9. Egan, A. F., J. Morris, G. Barnish, S. Allen, B. M. Greenwood, D. C. Kaslow, A. A. Holder, and E. M. Riley. 1996. Clinical immunity to Plasmodium falciparum malaria is associated with serum antibodies to the 19-kDa C-terminal fragment of the merozoite surface antigen, PfMSP-1. J. Infect. Dis. 173:765-769.
10. Färnert, A., I. Rooth, Å. Svensson, G. Snounou, and A. Björkman. 1999. Complexity of Plasmodium falciparum infections is consistent over time and protects against clinical disease in Tanzanian children. J. Infect. Dis. 179: 989-995.
11. Green, L. L., M. C. Hardy, C. E. Maynard-Currie, H. Tsuda, D. M. Louie, M. J. Mendez, H. Abderrahim, M. Noguchi, D. H. Smith, Y. Zeng, N. E. David, H. Sasai, D. Garza, D. G. Brenner, J. F. Hales, R. P. McGuinness, D. J. Capon, S. Klapholz, and A. Jakobovitsand. 1994. Antigen-specific human monoclonal antibodies from mice engineered with human Ig heavy and light chain YACs. Nat. Genet. 7:13-21.
12. Guevara Patin̄o, J. A., A. A. Holder, J. S. McBride, and M. J. Blackman. 1997. Antibodies that inhibit malaria merozoite surface protein-1 processing and erythrocyte invasion are blocked by naturally acquired human antibodies. J. Exp. Med. 186:1689-1699.
13. Holder, A. A., M. J. Blackman, P. A. Burghaus, J. A. Chappel, I. T. Ling, N. McCallum-Deighton, and S. Shai. 1992. A malaria merozoite surface protein (MSP1) - structure, processing and function. Mem. Inst. Oswaldo Cruz 87(Suppl. III):37-42.
14. Holder, A. A., J. S. Sandhu, Y. Hillman, L. S. Davey, S. C. Nicholls, H. Cooper, and M. J. Lockyer. 1987. Processing of the precursor to the major merozoite surface antigens of Plasmodium falciparum. Parasitology 94:199-208.
15. Jongwutiwes, S., K. Tanabe, and H. Kanbara. 1993. Sequence conservation in the C-terminal part of the precursor to the major merozoite surface proteins (MSP1) of Plasmodium falciparum from field isolates. Mol. Biochem. Parasitol. 59:95-100.
16. Khusmith, S., S. Tharavanij, M. Chongsa-Nguan, P. Tapchaisri, A. Sabchareon, and D. Bunnag. 1987. Human monoclonal anti-Plasmodium falciparum antibodies produced by stable EBV-transformed lymphocytes from patients with falciparum malaria. Southeast Asian J. Trop. Med. Public Health 18:24-32.
17. Liu, J., H. Shao, Y. Tao, B. Yang, L. Qian, X. Yang, B. Cao, G. Hu, H. Tachibana, and X. Cheng. 2006. Production of an anti-severe acute respiratory syndrome (SARS) coronavirus human monoclonal antibody Fab fragment by using a combinatorial immunoglobulin gene library derived from patients who recovered from SARS. Clin. Vaccine Immunol. 13:594-597.
18. Lundgren, K., M. Wahlgren, M. Troye-Blomberg, K. Berzins, H. Perlmann, and P. Perlmann. 1983. Monoclonal anti-parasite and anti-RBC antibodies produced by stable EBV-transformed B cell lines from malaria patients. J. Immunol. 131:2000-2003.
19. Lundquist, R., L. K. Nielsen, A. Jafarshad, D. Soesoe, L. H. Christensen, P. Druilhe, and M. H. Dziegiel. 2006. Human recombinant antibodies against Plasmodium falciparum merozoite surface protein 3 cloned from peripheral blood leukocytes of individuals with immunity to malaria demonstrate antiparasitic properties. Infect. Immun. 74:3222-3231.
20. Lyon, J. A., J. D. Haynes, C. L. Diggs, J. D. Chulay, C. G. Haidaris, and J. Pratt-Rossiter. 1987. Monoclonal antibody characterization of the 195-kilodalton major surface glycoprotein of Plasmodium falciparum malaria schizonts and merozoites: identification of additional processed products and a serotype-restricted repetitive epitope. J. Immunol. 138:895-901.
21. Mahanty, S., A. Saul, and L. H. Miller. 2003. Progress in the development of recombinant and synthetic blood-stage malaria vaccines. J. Exp. Biol. 206: 3781-3788.
22. McBride, J. S., and H. G. Heidrich. 1987. Fragments of the polymorphic Mr 185,000 glycoprotein from the surface of isolated Plasmodium falciparum merozoites form an antigenic complex. Mol. Biochem. Parasitol. 23:71-84.
23. 19 mapped by TROSY NMR. Mol. Biochem. Parasitol. 138:29-36.
24. Nwuba, R. I., O. Sodeinde, C. I. Anumudu, Y. O. Omosun, A. B. Odaibo, A. A. Holder, and M. Nwagwu. 2002. The human immune response to Plasmodium falciparum includes both antibodies that inhibit merozoite surface protein 1 secondary processing and blocking antibodies. Infect. Immun. 70:5328-5331.
25. 19 are a major component of the invasion-inhibitory response in individuals immune to malaria. J. Exp. Med. 193:1403-1412.
26. Pan, W., D. Huang, Q. Zhang, L. Qu, D. Zhang, X. Zhang, X. Xue, and F. Qian. 2004. Fusion of two malaria vaccine candidate antigens enhances product yield, immunogenicity, and antibody-mediated inhibition of parasite growth in vitro. J. Immunol. 172:6167-6174.
27. Pandey, K. C., S. Singh, P. Pattnaik, C. R. Pillai, U. Pillai, A. Lynn, S. K. Jain, and C. E. Chitnis. 2002. Bacterially expressed and refolded receptor binding domain of Plasmodium falciparum EBA-175 elicits invasion inhibitory antibodies. Mol. Biochem. Parasitol. 123:23-33.
28. Pang, X. L., and T. Horii. 1998. Complement-mediated killing of Plasmodium falciparum erythrocytic schizont with antibodies to the recombinant serine repeat antigen (SERA). Vaccine 16:1299-1305.
29. Pang, X. L., T. Mitamura, and T. Horii. 1999. Antibodies reactive with the N-terminal domain of Plasmodium falciparum serine repeat antigen inhibit cell proliferation by agglutinating merozoites and schizonts. Infect. Immun. 67:1821-1827.
30. Perera, K. L., S. M. Handunnetti, I. Holm, S. Longacre, and K. Mendis. 1998. Baculovirus merozoite surface protein 1 C-terminal recombinant antigens are highly protective in a natural primate model for human Plasmodium vivax malaria. Infect. Immun. 66:1500-1506.
31. Perraut, R., L. Marrama, B. Diouf, C. Sokhna, A. Tall, P. Nabeth, J. F. Trape, S. Longacre, and O. Mercereau-Puijalon. 2005. Antibodies to the conserved C-terminal domain of the Plasmodium falciparum merozoite surface protein 1 and to the merozoite extract and their relationship with in vitro inhibitory antibodies and protection against clinical malaria in a Senegalese village. J. Infect. Dis. 191:264-271.
32. Roeffen, W. F. G., J. M. H. Raats, K. Teelen, R. M. A. Hoet, W. M. Eling, W. J. van Venrooy, and R. W. Sauerwein. 2001. Recombinant human antibodies specific for the Pfs48/45 protein of the malaria parasite Plasmodium falciparum. J. Biol. Chem. 276:19807-19811.
33. Sakihama, N., M. Kimura, K. Hirayama, T. Kanda, K. Na-Bangchang, S. Jongwutiwes, D. Conway, and K. Tanabe. 1999. Allelic recombination and linkage disequilibrium within Msp-1 of Plasmodium falciparum, the malignant human malaria parasite. Gene 230:47-54.
34. Sakihama, N., H. Ohmae, B. Bakote'e, M. Kawabata, K. Hirayama, and K. Tanabe. 2006. Limited allelic diversity of Plasmodium falciparum merozoite surface protein 1 gene from populations in the Solomon Islands. Am. J. Trop. Med. Hyg. 74:31-40.
35. Siddiqui, W. A., L. Q. Tam, K. J. Kramer, G. S. Hui, S. E. Case, K. M. Yamaga, S. P. Chang, E. B. Chan, and S. C. Kan. 1987. Merozoite surface coat precursor protein completely protects Aotus monkeys against Plasmodium falciparum malaria. Proc. Natl. Acad. Sci. USA 84:3014-3018.
36. Snow, R. W., C. A. Guerra, A. M. Noor, H. Y. Myint, and S. I. Hay. 2005. The global distribution of clinical episodes of Plasmodium falciparum malaria. Nature 434:214-217.
37. Sowa, K. M., D. R. Cavanagh, A. M. Creasey, J. Raats, J. McBride, R. Sauerwein, W. F. Roeffen, and D. E. Arnot. 2001. Isolation of a monoclonal antibody from a malaria patient-derived phage display library recognising the block 2 region of Plasmodium falciparum merozoite surface protein-1. Mol. Biochem. Parasitol. 112:143-147.
38. Stafford, W. H., M. J. Blackman, A. Harris, S. Shai, M. Grainger, and A. A. Holder. 1994. N-terminal amino acid sequence of the Plasmodium falciparum merozoite surface protein-1 polypeptides. Mol. Biochem. Parasitol. 66:157-160.
39. Tachibana, H., X. J. Cheng, K. Watanabe, M. Takekoshi, F. Maeda, S. Aotsuka, Y. Kaneda, T. Takeuchi, and S. Ihara. 1999. Preparation of recombinant human monoclonal antibody Fab fragments specific for Entamoeba histolytica. Clin. Diagn. Lab. Immunol. 6:383-387.
40. Tachibana, H., N. Matsumoto, X. J. Cheng, H. Tsukamoto, and E. Yoshihara. 2004. Improved affinity of a human anti-Entamoeba histolytica Gal/ GalNAc lectin Fab fragment by a single amino acid modification of the light chain. Clin. Diagn. Lab. Immunol. 11:1085-1088.
41. Tachibana, H., K. Watanabe, X. J. Cheng, H. Tsukamoto, Y. Kaneda, T. Takeuchi, S. Ihara, and W. A. Petri, Jr. 2003. VH3 gene usage in neutralizing human antibodies specific for the Entamoeba histolytica Gal/GalNAc lectin heavy subunit. Infect. Immun. 71:4313-4319.
42. Takekoshi, M., F. Maeda, H. Tachibana, H. Inoko, S. Kato, I. Takakura, T. Kenjyo, S. Hiraga, Y. Ogawa, T. Horiki, and S. Ihara. 1998. Human monoclonal anti-HCMV neutralizing antibody from phage display libraries. J. Virol. Methods 74:89-98.
43. Tanabe, K., M. Mackay, M. Goman, and J. G. Scaife. 1987. Allelic dimorphism in a surface antigen gene of the malaria parasite Plasmodium falciparum. J. Mol. Biol. 195:273-287.
44. Tomizuka, K., H. Yoshida, H. Uejima, H. Kugoh, K. Sato, A. Ohguma, M. Hayasaka, K. Hanaoka, M. Oshimura, and I. Ishida. 1997. Functional expression and germline transmission of a human chromosome fragment in chimaeric mice. Nat. Genet. 16:133-143.
45. Trager, W., and J. B. Jensen. 1976. Human malaria parasites in continuous culture. Science 193:673-675.
46. Trager, W., and H. N. Lanners. 1984. Initial extracellular development in vitro of merozoites of Plasmodium falciparum. J. Protozool. 31:562-567.
47. Udomsangpetch, R., K. Lundgren, K. Berzins, B. Wahlin, H. Perlmann, M. Troye-Blomberg, J. Carlsson, M. Wahlgren, P. Perlmann, and A. Bjorkman. 1986. Human monoclonal antibodies to Pf 155, a major antigen of malaria parasite Plasmodium falciparum. Science 231:57-59.
48. Uthaipibull, C., B. Aufiero, S. E. Syed, B. Hansen, J. A. Guevara Patino, E. Angov, I. T. Ling, K. Fegeding, W. D. Morgan, C. Ockenhouse, B. Birdsall, J. Feeney, J. A. Lyon, and A. A. Holder. 2001. Inhibitory and blocking monoclonal antibody epitopes on merozoite surface protein 1 of the malaria parasite Plasmodium falciparum. J. Mol. Biol. 307:1381-1394.
49. Wajanarogana, S., T. Prasomrothanakul, R. Udomsangpetch, and S. Tungpradabkul. 2006. Construction of a human functional single-chain variable fragment (scFv) antibody recognizing the malaria parasite Plasmodium falciparum. Biotechnol. Appl. Biochem. 44:55-61.